Navilyst Medical
Navilyst Medical Inc. designed and manufactured implantable Vortex port catheters for long-term vascular access in chemotherapy and infusion therapy. Founded in 2008 as a subsidiary of AngioDynamics Inc., the entity has been consolidated into its parent company.
- Company typePrivate
- Founded2008
- HeadquartersMarlborough, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Navilyst Medical firmographics
Firmographics- Name
- Navilyst Medical
- Legal name
- Navilyst Medical Inc.
- Website
- https://navilystmedical.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Acquired
- Headcount range
- 501–1,000 employees
- Short description
- Navilyst Medical Inc. designed and manufactured implantable Vortex port catheters for long-term vascular access in chemotherapy and infusion therapy. Founded in 2008 as a subsidiary of AngioDynamics Inc., the entity has been consolidated into its parent company.
- Ownership category
- akta.pro rank
Navilyst Medical industry classification
Industry- Product category
- Medical Devices - Vascular Access
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)
- akta.pro secondary industries
- Infusion Sets, Catheters & Pump Consumables (HLAHAIAH), Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)
Keywords
Where Navilyst Medical is headquartered
LocationHeadquarters
- HQ city
- Marlborough
- HQ country
- United States
- HQ region
- North America
Markets served
Navilyst Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Navilyst Medical product offering
Product offeringCore offering
Navilyst Medical develops, manufactures, and markets implantable vascular access medical devices, with its flagship product being the Vortex Port Catheter. These implantable port catheters are designed for long-term venous access to deliver intravenous therapies, chemotherapy, blood products, and other infusions in clinical settings.
Differentiator
Problem solved
Functional benefit
Products and services
- Vortex Port Catheters
Companies that use Navilyst Medical
Customer profileSegments1 record
Ideal customer profiles1 record
Navilyst Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Navilyst Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AngioDynamics Inc.coreNavilyst Medical was sued alongside AngioDynamics Inc. in a product liability lawsuit regarding Vortex port catheters. The complaint alleges defects in design and manufacturing of these catheters led to device migration, infection, and blood clots. This suggests Navilyst Medical may be a subsidiary or closely related entity to AngioDynamics Inc.
Navilyst Medical competitors and assessment
Company assessmentDirect peers
- AngioDynamics: Parent company and direct operator of Navilyst's vascular access and oncology catheter portfolio. AngioDynamics sells port catheters and related infusion access devices through overlapping hospital channels, making it the most directly comparable entity.
- Smiths Medical (ICU Medical): Smiths Medical (now part of ICU Medical) manufactures implantable port catheters and vascular access devices targeting chemotherapy infusion and long-term venous access — a direct competitive overlap with Vortex Port Catheters.
Broad incumbents
- Becton, Dickinson and Company (BD): Global medical device incumbent with a large vascular access franchise (including the PowerPort and port catheter lines) serving the same oncology and long-term IV therapy customers as Navilyst.
- B. Braun: Major diversified medical device and IV therapy company offering port systems, infusion sets, and vascular access consumables that compete with Navilyst's catheter offerings in hospital and oncology settings.
- Teleflex: Broad-line medical device manufacturer with a vascular access and infusion portfolio (including Arrow branded catheters) that overlaps with Navilyst's chemotherapy and long-term venous access use cases.
- ICU Medical: Specialist in IV therapy, infusion systems, and vascular access devices serving hospitals and oncology clinics; its product lines directly overlap with Navilyst's chemotherapy port catheter application.
- Terumo: Global medical device company with implantable port systems and infusion access devices used in oncology and long-term IV therapy, representing a credible competing technology platform.
- Medtronic: Diversified medical device leader with vascular and infusion-related offerings serving similar hospital and oncology end-markets, although its catheter portfolio is broader and less focused on implantable ports.
Emerging players
- Fresenius Kabi: Specializes in infusion therapy, IV drugs, and clinical nutrition with a growing medical device portfolio in vascular access; overlapping customer base with Navilyst in oncology infusion settings.
Others
- Edwards Lifesciences: Cardiovascular-focused device maker with vascular access and monitoring capabilities relevant to hospital infusion workflows; comparable in clinical setting but not a direct port catheter competitor.
Market position
Customer concentration
Navilyst Medical social profiles
Digital presenceNavilyst Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Navilyst Medical leadership team
Management profileNumber of profiles
Profiles1 record
Navilyst Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Navilyst Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Navilyst Medical
What does Navilyst Medical do?
Navilyst Medical develops, manufactures, and markets implantable vascular access medical devices, with its flagship product being the Vortex Port Catheter. These implantable port catheters are designed for long-term venous access to deliver intravenous therapies, chemotherapy, blood products, and other infusions in clinical settings.
Is Navilyst Medical a public or private company?
Navilyst Medical is a private company. It is classified as corporate owned and is currently acquired.
When was Navilyst Medical founded?
Navilyst Medical was founded in 2008. It employs 501 to 1,000 people.
Where is Navilyst Medical based?
Navilyst Medical is headquartered in Marlborough, United States, in the North America region.
Who are Navilyst Medical's main competitors?
Direct peers on record are AngioDynamics and Smiths Medical (ICU Medical). Broad incumbents are Becton, Dickinson and Company (BD), B. Braun, Teleflex, ICU Medical, Terumo and Medtronic. Fresenius Kabi is listed as an emerging player. Edwards Lifesciences is listed as an others.
Does Navilyst Medical have an API?
No public API is recorded for Navilyst Medical.
What industry is Navilyst Medical in?
Navilyst Medical's product category is Medical Devices - Vascular Access. Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories), with a secondary code of HLAHAIAH, Infusion Sets, Catheters & Pump Consumables. Its NAICS code is 339113 and its SIC code is 3841.